Startup based in the United States, most recent round Series-c-plus, 3 tracked investors.
Based in the United States, Alcresta Therapeutics is a startup founded in 2014. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Alcresta Therapeutics is a commercial-stage company that develops and commercializes innovative enzyme-based products for patients with digestive disorders and rare diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.